Literature DB >> 29849811

Downregulation of microRNA-142-3p and its tumor suppressor role in gastric cancer.

Yi Wang1, Zhidong Cao2,3, Lanlan Wang4, Siqi Liu4, Jianqiang Cai5.   

Abstract

An increasing number of studies indicate that microRNAs (miRNAs) may exert an oncogenic or tumor suppressive role in diverse types of cancer. MicroRNA (miR)-142-3p has been detected to be downregulated in a number of cancer types, and it may function as a tumor suppressor. However, the expression profile and potential role of miR-142-3p in gastric cancer remain unknown. In the present study, the expression of miR-142-3p in numerous gastric cancer samples was investigated. It was observed that miR-142-3p was markedly downregulated in cancer tissues compared with normal tissues. Furthermore, a low expression level of miR-142-3p was associated with higher tumor stages. The overexpression of miR-142-3p was able to inhibit the proliferation, invasion and migration of gastric cancer cells. A further investigation into the mechanism underlying the effect of miR-142-3p identified cyclin T2 (CCNT2) as a target of miR-142-3p in gastric cancers. miR-142-3p may exert its tumor suppressor role partially by downregulating CCNT2. These results suggested that the abnormal downregulation of miR-142-3p and the subsequent increase in CCNT2 expression may have an important role in gastric cancer carcinogenesis.

Entities:  

Keywords:  cyclin T2; gastric cancer; microRNA-142-3p; tumor suppressor

Year:  2018        PMID: 29849811      PMCID: PMC5962855          DOI: 10.3892/ol.2018.8330

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  36 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  CDC2-related kinase PITALRE phosphorylates pRb exclusively on serine and is widely expressed in human tissues.

Authors:  A De Luca; V Esposito; A Baldi; P P Claudio; Y Fu; M Caputi; M M Pisano; F Baldi; A Giordano
Journal:  J Cell Physiol       Date:  1997-08       Impact factor: 6.384

3.  MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma.

Authors:  Changzheng Liu; Jia Yu; Shuangni Yu; Robert M Lavker; Lei Cai; Wei Liu; Kegong Yang; Xiaodong He; Songsen Chen
Journal:  J Hepatol       Date:  2010-04-04       Impact factor: 25.083

Review 4.  CDK9 (PITALRE): a multifunctional cdc2-related kinase.

Authors:  G de Falco; A Giordano
Journal:  J Cell Physiol       Date:  1998-12       Impact factor: 6.384

5.  Physical interaction between pRb and cdk9/cyclinT2 complex.

Authors:  Cristiano Simone; Luigi Bagella; Cristiana Bellan; Antonio Giordano
Journal:  Oncogene       Date:  2002-06-13       Impact factor: 9.867

6.  miR-142-3p down-regulation contributes to thyroid follicular tumorigenesis by targeting ASH1L and MLL1.

Authors:  Marianna Colamaio; Francesca Puca; Elvira Ragozzino; Marica Gemei; Myriam Decaussin-Petrucci; Concetta Aiello; André Uchimura Bastos; Antonella Federico; Gennaro Chiappetta; Luigi Del Vecchio; Liborio Torregrossa; Sabrina Battista; Alfredo Fusco
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

7.  MiR-142-3p represses TGF-β-induced growth inhibition through repression of TGFβR1 in non-small cell lung cancer.

Authors:  Zhe Lei; Guili Xu; Longqiang Wang; Haiping Yang; Xia Liu; Jun Zhao; Hong-Tao Zhang
Journal:  FASEB J       Date:  2014-02-20       Impact factor: 5.191

Review 8.  Efficacy of Helicobacter pylori eradication for the prevention of metachronous gastric cancer after endoscopic resection for early gastric cancer.

Authors:  Jae Young Jang; Hoon Jai Chun
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

9.  Cyclin T2 is essential for mouse embryogenesis.

Authors:  Jiri Kohoutek; Qintong Li; Dalibor Blazek; Zeping Luo; Huimin Jiang; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2009-04-13       Impact factor: 4.272

Review 10.  Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies.

Authors:  Angela Hui; Christine How; Emma Ito; Fei-Fei Liu
Journal:  BMC Cancer       Date:  2011-11-30       Impact factor: 4.430

View more
  11 in total

1.  IGF2-AS affects the prognosis and metastasis of gastric adenocarcinoma via acting as a ceRNA of miR-503 to regulate SHOX2.

Authors:  Ju Huang; You-Xiang Chen; Bo Zhang
Journal:  Gastric Cancer       Date:  2019-06-10       Impact factor: 7.370

2.  MicroRNA‑142‑3p suppresses cell proliferation, invasion and epithelial‑to‑mesenchymal transition via RAC1‑ERK1/2 signaling in colorectal cancer.

Authors:  Na Xie; Qiuping Meng; Yixin Zhang; Zhifei Luo; Fenggui Xue; Sisi Liu; Ying Li; Yousheng Huang
Journal:  Mol Med Rep       Date:  2021-06-10       Impact factor: 2.952

3.  Co-regulatory Network of Oncosuppressor miRNAs and Transcription Factors for Pathology of Human Hepatic Cancer Stem Cells (HCSC).

Authors:  Rania Hassan Mohamed; Nourhan Abu-Shahba; Marwa Mahmoud; Ahmed M H Abdelfattah; Wael Zakaria; Mahmoud ElHefnawi
Journal:  Sci Rep       Date:  2019-04-03       Impact factor: 4.379

4.  Down-regulation of microRNA-142-3p inhibits the aggressive phenotypes of rheumatoid arthritis fibroblast-like synoviocytes through inhibiting nuclear factor-κB signaling.

Authors:  Jianhong Qiang; Tingting Lv; Zhenbiao Wu; Xichao Yang
Journal:  Biosci Rep       Date:  2019-07-08       Impact factor: 3.840

5.  Decitabine shows anti-acute myeloid leukemia potential via regulating the miR-212-5p/CCNT2 axis.

Authors:  Lina Xing; Jinhai Ren; Xiaonan Guo; Shukai Qiao; Tian Tian
Journal:  Open Life Sci       Date:  2020-12-31       Impact factor: 0.938

6.  Genetic predisposition and prediction protocol for epithelial neoplasms in disease-free individuals: A systematic review.

Authors:  J Gowthami; N Gururaj; V Mahalakshmi; R Sathya; T R Sabarinath; Daffney Mano Doss
Journal:  J Oral Maxillofac Pathol       Date:  2020-09-09

7.  Upregulation of circRNA_100395 sponges miR-142-3p to inhibit gastric cancer progression by targeting the PI3K/AKT axis.

Authors:  Zhiyi Cheng; Guiyuan Liu; Chuanjiang Huang; Xiaojun Zhao
Journal:  Oncol Lett       Date:  2021-03-28       Impact factor: 2.967

8.  circCUL2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p/ROCK2.

Authors:  Lei Peng; Huaiming Sang; Shuchun Wei; Yuanyuan Li; Duochen Jin; Xudong Zhu; Xuan Li; Yini Dang; Guoxin Zhang
Journal:  Mol Cancer       Date:  2020-11-05       Impact factor: 27.401

Review 9.  Involvement of miR-142 and miR-155 in Non-Infectious Complications of CVID.

Authors:  Giuliana Amato; Federica Vita; Paolina Quattrocchi; Paola Lucia Minciullo; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Molecules       Date:  2020-10-16       Impact factor: 4.411

10.  USP6NL mediated by LINC00689/miR-142-3p promotes the development of triple-negative breast cancer.

Authors:  Teng Ma; Huaidong Liu; Yan Liu; Tingting Liu; Hui Wang; Fulu Qiao; Lu Song; Lin Zhang
Journal:  BMC Cancer       Date:  2020-10-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.